Bucogel

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bucogel

Quick Facts

Property Description
Active Ingredient Chlorhexidine Digluconate
Form Dental Gel (mucoadhesive)
Pharmacological Class Antimicrobial, Antiseptic (bisbiguanide)
Common Use Oral hygiene maintenance, plaque inhibition
Origin Synthetic

What Type of Preparation is Bucogel?

Bucogel is categorized as a specialized topical preparation and Dental Gel primarily intended for maintaining oral hygiene through its powerful antimicrobial activity. Its foundational chemical component is Chlorhexidine Digluconate, a well-established synthetic compound that acts as a broad-spectrum Antiseptic and Germicide. This classification defines the product's role as an active agent designed to effectively reduce the microbial load within the mouth. The bisbiguanide compound class of Chlorhexidine is recognized for its efficacy in reducing dental plaque and gingivitis. This active compound is administered via the buccal administration route, ensuring direct contact with the oral surfaces where microbial action is needed.

Composition and General Oral Hygiene Purpose

Bucogel is a combination product delivered in a viscous hydrogel base engineered to be mucoadhesive, a key differentiating feature that allows it to stick effectively to the gums and teeth for sustained action. The essential antiseptic component is Chlorhexidine Digluconate, supplemented by other functional ingredients such as Centella Asiatica, which is recognized for supporting tissue health, and mineral components like Zinc lactate dihydrate. This specific formulation is often positioned for patients requiring more intensive oral maintenance. Chlorhexidine preparations are characterized by their ability to reduce plaque accumulation and inhibit the formation of calculus. The general purpose of this formulation is to limit factors that contribute to common oral health issues, including the accumulation of bacterial films known as plaque and the development of gum irritation.

The Mechanism of Sustained Antiseptic Action

The sustained efficacy of Bucogel stems from the fundamental concept of substantivity, which is achieved by the strong cationic binding of Chlorhexidine molecules to the anionic surfaces of the oral cavity. This unique mechanism ensures that the antiseptic agent is retained on the oral surfaces for a prolonged period after application, which is a key concept behind its sustained effectiveness. This binding initiates a rapid germicidal effect by disrupting the integrity of the bacteria, serving as a chemical means of inhibiting bacterial accumulation long after application.

What side effects are possible with Bucogel?

Possible Side Effects and Safety Information

The safety profile for this dental gel is characterized by a high incidence of local oral effects and the rare documentation of systemic allergic reactions, as defined in official regulatory documents. Most adverse reactions are linked to the drug's topical action within the mouth.


Frequency-Classified Adverse Reactions

Adverse reactions are classified according to standard regulatory frequency categories:

  • Very Common: Transient disturbances of taste sensation (dysgeusia, altered taste).
  • Common: Discolouration of the teeth and tongue (extrinsic staining), burning sensation or soreness of the oral mucosa, and increased supragingival calculus formation.
  • Very Rare: Anaphylactic reaction (anaphylaxis), a severe, systemic allergic event documented in post-marketing surveillance.

Common side effects, such as discoloration and altered taste, are generally associated with continued or long-term exposure, while sensations of irritation may be transient and occur at the start of treatment.


Safety Restrictions and Considerations

Official labeling includes specific safety constraints. The product is strictly contraindicated for use in persons with a known history of hypersensitivity or allergic reaction to chlorhexidine or any other ingredient. Treatment may need to be discontinued if extensive desquamation (peeling of the oral lining) occurs.

The activity of the gel may be reduced if used simultaneously with certain anionic agents found in common toothpastes, a factor noted as relevant to its intended safety and efficacy profile.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile for Bucogel (Chlorhexidine Digluconate) based on two primary risks that require emergency intervention: Accidental Systemic Ingestion and Acute Hypersensitivity Reaction.

Documented Overdose Manifestations

Accidental swallowing of large volumes may lead to systemic toxicity. Manifestations documented in regulatory information include gastric distress, nausea, and, with severe exposure, central nervous system effects such as drowsiness and unconsciousness. Cardiovascular effects like low blood pressure and rapid heart rate have also been reported. Regulatory guidance specifically notes that small children who ingest large volumes should seek medical attention.

Severe Outcomes and Emergency Actions

The regulatory profile highlights the risk of a serious allergic reaction (anaphylaxis). Regulators explicitly state this reaction can be life-threatening, potentially involving shock and respiratory distress (e.g., wheezing). Immediate medical attention or calling emergency services is strictly mandated for any sign of a serious allergic reaction, or if large quantities are swallowed. No specific antidote is known, and treatment is officially defined as symptomatic and supportive. Procedural measures documented for accidental ingestion may include gastric lavage or stomach washout using demulcents.

Therapeutic Uses of Bucogel

What Bucogel Treats: Main Uses and Benefits

Bucogel is a specialized dental gel applied across therapeutic domains involving inflammatory or irritative states within the mouth. The gel is commonly used across conditions presenting with acute or disruptive symptom patterns, which is relevant in managing the symptoms associated with these conditions. Indications generally include the management of localized symptoms of gingivitis (inflamed and bleeding gums), oral ulcers (mouth sores), and specific irritations such as denture stomatitis.

Symptom Management and Supportive Care

This therapeutic gel is used in situations involving certain distressing symptoms, primarily targeting the redness, swelling, and irritation of the gum tissue. The use of this preparation generally supports the patient during difficult episodes by helping to ease the inflammatory distress, which contributes to easing the overall symptom load. It is often utilized in clinical settings that involve acute or unstable symptom patterns, such as following dental extractions or surgery, or when mechanical cleaning is restricted. This application may assist with maintaining functional stability and comfort during symptomatic periods.

Quick Fact Relief for Symptom
Primary Use Supports management of gum inflammation and bleeding.
Secondary Use Assists with comfort for oral ulcers and mucosal irritation.
Clinical Context Applied for short-term symptomatic assistance post-procedure.

Eligibility and Restrictions for Use

Contraindicated Populations

Bucogel is strictly contraindicated for individuals with a documented history of hypersensitivity or severe allergic reaction to Chlorhexidine Digluconate or to any of the specific excipients in the dental gel formulation. Use must be avoided by anyone with a potential history of an allergic reaction to chlorhexidine compounds.


Age and Pediatric Eligibility

The medicine is established for use by adults and elderly patients, for whom the standard adult dose is appropriate. Use is not recommended for children under 12 years of age unless the product is specifically advised by a healthcare professional. Regulatory data from some regions indicate that clinical safety and effectiveness have not been established for use in adolescents under 18 years.


Conditional Use and Restrictions

  • Pregnancy and Lactation: Use in pregnant individuals and nursing mothers requires caution or is permitted only if clearly needed. This restriction is due to the unknown status of drug excretion into human milk.
  • Organ Function: No explicit restrictions are documented in the official labeling regarding use limitations for patients with hepatic impairment (liver problems) or renal impairment (kidney problems).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Bucogel (Chlorhexidine Digluconate Dental Gel) is defined primarily by its minimal systemic absorption, which limits the potential for interactions with systemic medicines.

Pharmacokinetic and Systemic Interactions

Regulatory documentation confirms the absence of documented systemic pharmacokinetic interactions with other medicines. Chlorhexidine is poorly absorbed into the bloodstream from the gastrointestinal tract, meaning interactions involving hepatic enzymes (e.g., CYP-mediated) or drug transporters are generally not relevant to the product’s systemic profile.


Local Pharmacodynamic and Timing Constraints

Due to the active ingredient's cationic nature, a key officially documented interaction is the pharmacodynamic inactivation of Chlorhexidine by anionic agents. These substances, such as those found in conventional toothpastes, can neutralize the gel’s efficacy and reduce its local retention (substantivity).

Consequently, the prescribing information includes specific timing requirements to prevent functional interactions and loss of effect. These restrictions mandate a time separation between gel application and the use of other oral rinsing agents (such as water or mouthwashes) and the consumption of food or drinks.

Mechanism of Action

Cationic Disruption and Localized Antiseptic Action

The primary component, Chlorhexidine, exerts a germicidal effect by strong cationic binding to the negatively charged bacterial cell membrane, causing immediate physical disruption and subsequent leakage of cellular contents. This unique interaction simultaneously facilitates substantivity, where the molecule binds to oral surfaces to create a localized sustained-release reservoir, supporting the continuous presence of the active agent on oral surfaces.

Synergy for Metabolic and Structural Modulation

The formulation acts through two complementary mechanistic domains. Zinc ions ( Zn^2+) contribute to the antimicrobial profile by inhibiting essential bacterial metabolic enzymes and interfering with the mineralization cascade that forms calculus. Parallel to this, the triterpenoids from Centella Asiatica act as modulators of fibroblast activity, influencing the synthesis of collagen and the organization of the gingival connective tissue.

Dosage and Administration Information

How to Use Bucogel: Administration Guidelines

Bucogel (Chlorhexidine Digluconate Dental Gel) is administered via the topical oromucosal route. The application is localized to the oral cavity, and the gel must not be swallowed; any excess should be spat out after application.


Dosing and Administration Schedule

Feature Standard Guidelines
Standard Adult Dose For treatment of gingivitis, approximately 2.5 cm (one inch) of gel is applied onto a moistened toothbrush. For local lesions, such as oral ulcers, a small amount is applied directly to the affected area.
Frequency The gel is typically applied once or twice daily.
Duration of Use For gingivitis (gum inflammation), a treatment course of approximately one month is generally advised. For oral ulcers, application should continue for 48 hours after symptoms have cleared (clinical resolution).

Procedural Requirements and Constraints

The administration protocol includes specific steps to prevent the inactivation of the active ingredient and to ensure adherence to the stated dose.

  • Chemical Compatibility Constraint: It is essential to rinse the mouth thoroughly with water and wait a minimum of five minutes after using conventional anionic toothpaste (dentifrice) before applying the gel. This rule prevents the toothpaste components from chemically inactivating the chlorhexidine.
  • Application Method: When used for brushing, apply the dose to a moistened toothbrush. After any application, the mouth should not be rinsed immediately to maintain the gel's substantivity and local action.
  • Age-Specific Rules: The standard adult dose is considered appropriate for elderly patients and children aged 12 years and over. The gel is not indicated for children under 12 years unless a healthcare professional is consulted. The stated dose must not be exceeded.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bucogel (Chlorhexidine Digluconate Dental Gel)


Evidence for Use in Managing Gingivitis

Research examining the use of this gel formulation often involves Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies are used in research exploring how symptoms change over time in adults diagnosed with chronic inflammation of the gums, known as gingivitis. Researchers focus on outcomes related to inflammatory or irritative states by monitoring physiological strain or stress in the gums.

The studies explore how application of the gel relates to changes in widely accepted clinical measurements for gum health, known as the Plaque Index (PI) and the Gingival Index (GI). Studies report how symptoms evolved in the observed populations across these indices. Studies explored the use of the gel in research contexts involving fluctuating or unstable symptoms. Long-term effects are not fully established, and follow-up durations were typically limited to short- to intermediate-term observation periods.


Evidence for Post-Procedure Oral Care

The gel was also evaluated in research exploring short-term symptom changes following minor dental procedures, such as tooth extractions. This research often utilizes RCTs and Meta-analyses conducted during periods of increased symptom activity after surgery. Studies monitored outcomes related to functional imbalance and outcomes describing episodic or acute changes in the oral cavity.

Studies focused on episodes where symptoms become more noticeable, particularly the incidence of post-operative complications (like "dry socket"). Research explored the application of the gel in this context, and studies examined the incidence of these specific issues. Pain scores were recorded and described using patient-reported outcomes describing perceived discomfort in the observed populations. A key limitation is that results apply only to the populations studied—predominantly adults undergoing common surgeries.


What is Still Uncertain About the Research

Scientific reviews highlight several research limitations. While the evidence is well-characterized for its effect on specific plaque and gum indices, data quality varies across studies, and comparative evidence is lacking in some areas. Data are still emerging, and there are few data available for special populations like children or pregnant individuals. The sample sizes were modest in some of the trials related to oral ulcers, and long-term research is ongoing to better understand continuous use.

Key Studies & References

  1. Efficacy of Chlorhexidine after Oral Surgery Procedures on Wound Healing: Systematic Review and Meta-Analysis

Frequently Asked Questions (FAQ)

Common questions about Bucogel (FAQ)

Q: Is Bucogel the same as [Commonly confused Drug X]?

Bucogel is a brand-name dental gel containing the active ingredient Chlorhexidine Digluconate. While Chlorhexidine is widely used and found in many oral products, Bucogel is specifically described in official documents as a combination product. This formulation includes Chlorhexidine alongside Zinc and a component from Centella Asiatica, which contributes to its unique composition compared to single-active ingredient products.


Q: Why do people say Bucogel is better than other treatments?

Official product information describes this formulation as having a multi-component mechanism of action. This includes the proven antiseptic effect of Chlorhexidine, the enzyme-inhibiting action of Zinc ions, and tissue-supportive properties from Centella Asiatica. This specific combination of ingredients is often the focus of research when comparing the product to other oral treatments.


Q: Does Bucogel cause weight gain?

According to the official safety profile for the dental gel, weight gain is not listed among the classified adverse reactions (Very Common, Common, or Rare). Most adverse effects associated with this topical product are local to the oral cavity, such as taste disturbance or staining.


Q: Can Bucogel be used for conditions not listed in the main uses?

Regulatory documents state that the product is officially indicated only for the management of gingivitis (gum inflammation) and as an aid for post-procedure oral care. Use for any other conditions is not supported by the officially listed therapeutic indications.


Q: What is the difference between Bucogel and a placebo in clinical trials?

Research evidence from clinical trials reports that the application of the gel leads to statistically significant improvements in clinical measurements for gum health, such as the Plaque Index and Gingival Index, when compared to an inert placebo. These studies describe the product's use as correlating with positive changes in inflammation and microbial indices.


Q: Can I take Bucogel if I'm already taking blood pressure medicine?

Regulatory documentation confirms the absence of documented systemic pharmacokinetic interactions with other medicines, including blood pressure medication. This is due to the active ingredient being poorly absorbed into the bloodstream from the gastrointestinal tract, minimizing the potential for interactions outside of the mouth.


Q: What are the inactive ingredients in Bucogel?

Bucogel is delivered in a specialized hydrogel base which contains excipients necessary for its texture and stability. These may include thickening agents like Hydroxypropylcellulose, along with flavorings such as Peppermint Oil, and may contain small amounts of Isopropyl alcohol as a solvent.


Q: Is there a generic version of Bucogel available?

The active ingredient, Chlorhexidine Digluconate, is a common antiseptic compound available in many generic and branded oral products globally. However, Bucogel is marketed as a brand name due to its specific combination of Chlorhexidine with Zinc and Centella Asiatica.


Q: Can Bucogel affect my driving ability?

Official regulatory information states that the product has no or negligible effect on the ability to drive or operate machinery. This is consistent with the product's topical administration and its minimal absorption into the bloodstream.


Q: Is Bucogel safe to take before surgery?

The gel is primarily studied and indicated for post-procedure care. Due to the rare, but documented, risk of a severe systemic allergic reaction (anaphylaxis), consultation with a healthcare professional regarding timing and necessity before surgery is recommended.


Q: Can I drink alcohol while using Bucogel?

Official administration protocols require a time separation between gel application and the consumption of all food or drinks to maintain the gel’s local efficacy (substantivity). Some formulations may also contain a small amount of alcohol as an inactive ingredient, and this should be considered.


Q: Is Bucogel safe for children and teenagers?

Official documentation states that the product is contraindicated (use must be avoided) for children under 12 years of age. For adolescents aged 12 to 18, the standard adult dose is considered suitable, although some regulatory information notes that clinical safety and effectiveness have not been fully established for this entire age range.


Q: Are the active ingredients in Bucogel commonly found in other medicines?

The primary component, Chlorhexidine Digluconate, is a well-established synthetic compound that is frequently used as an antiseptic in many types of topical and oral products. However, the specific combination with Zinc and Centella Asiatica triterpenoids is unique to this specific dental gel preparation.


Q: What is the risk of dependence or addiction with Bucogel?

There is no known risk of dependence or addiction associated with the use of Chlorhexidine Digluconate Dental Gel. It is a topical antiseptic, and regulatory documents do not associate it with a risk of dependence.


Q: Does Bucogel cause dry mouth or blurred vision?

A sensation of dry mouth is a documented, non-serious side effect that is common with chlorhexidine oral products. However, blurred vision or other visual disturbances are not listed as a reported adverse reaction in the official safety profile.


Q: Can people with kidney or liver issues use Bucogel?

Official regulatory labeling contains no explicit restrictions or dosage adjustments for patients with hepatic (liver) or renal (kidney) impairment. This is consistent with the product's very low systemic absorption, meaning it does not heavily rely on the liver or kidneys for processing.


Q: What percentage of people see an effect from Bucogel in clinical trials?

Research describes the product’s efficacy in terms of statistically significant positive outcomes observed in the treated population, such as a reduction in the Plaque Index. While studies confirm a clear effect compared to placebo, a single universal 'success rate' percentage is not cited in authoritative product information.


Q: Is it possible to be immune to the effects of Bucogel?

Chlorhexidine's germicidal effect is achieved primarily through the physical disruption of bacterial cell membranes. While the physical mechanism is defined, research has examined the potential for a reduced susceptibility or tolerance in some microorganisms following sustained exposure.


Q: What is the overall safety profile of Bucogel described as in official documents?

The safety profile describes a product characterized by being generally well-tolerated, with most adverse reactions being non-serious and local oral effects (e.g., taste change, staining). Severe, systemic allergic events like anaphylaxis are documented, but are considered very rare.

How should Bucogel be stored and disposed of?

How to Store and Dispose of Bucogel

Official regulatory guidelines define specific conditions to maintain the stability and safety of this dental gel. Bucogel must be stored at a temperature below 25°C (77°F) to protect the active ingredient. Storage must always be in the original container.


Stability and Child Safety

Once the tube is opened, the product should be used within 28 days. A mandatory requirement is that the gel must be kept out of the sight and reach of children.


Disposal Requirements

Unused or expired Bucogel should not be disposed of via wastewater or in standard household refuse. To ensure environmental protection, the product must be returned to a pharmacist or local waste disposal service for proper collection as pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bucogel found in:

A-Z Index: